BNP (B-type Natriuretic Peptide) vs TB-500

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

BNP (B-type Natriuretic Peptide)

BNP is a cardiac neurohormone released primarily by ventricles in response to volume/pressure overload. It's a major biomarker for heart failure and has therapeutic applications as nesiritide.

Full details →

TB-500

Thymosin Beta-4 (TB-500) is a naturally occurring peptide present in almost all human and animal cells. It plays a crucial role in tissue repair and regeneration.

Full details →

Side-by-Side Comparison

Aspect	BNP (B-type Natriuretic Peptide)	TB-500
Dose Range	25 mcg–100 mcg	2 mg–2.5 mg
Frequency	1x daily	Less than daily
Cycle Length	1–4 weeks	4–8 weeks
Route	subcutaneous	subcutaneous
Mechanism	Similar to ANP - activates NPR-A receptors to produce vasodilation, natriuresis, and RAAS suppression. Released in response to ventricular wall stress.	TB-500 promotes cell migration and differentiation, regulates actin (a cell-building protein), and reduces inflammation. It supports the formation of new blood vessels and wound healing.
Typical Dosage	Nesiritide (recombinant BNP): 2mcg/kg IV bolus followed by 0.01mcg/kg/min continuous infusion for acute decompensated heart failure.	Research protocols typically use 2-2.5mg twice weekly during the loading phase, followed by maintenance dosing of 2mg every 2 weeks.
Administration	Intravenous administration only. Used in acute care settings for heart failure. BNP levels also used diagnostically.	Administered via subcutaneous or intramuscular injection. Some protocols suggest injection near injury sites.
Side Effects	Hypotension (common and dose-limiting), headache, nausea, and potential renal function worsening in some patients.	May cause temporary fatigue, headache, or localized irritation at injection sites.
Best For	Recovery & Healing	Muscle Growth Recovery & Healing